BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 10917377)

  • 1. Reversible granulocytopenia in association with riluzole therapy.
    North WA; Khan AM; Yamase HT; Sporn JR
    Ann Pharmacother; 2000 Mar; 34(3):322-4. PubMed ID: 10917377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I; Camu W; Hillaire-Buys D
    Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Riluzole-induced recurrent pancreatitis.
    Falcão de Campos C; de Carvalho M
    J Clin Neurosci; 2017 Nov; 45():153-154. PubMed ID: 28867362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L; Dib M; Doppler V; Faudet A; Robin V; Salachas F; Bensimon G; Meininger V
    Therapie; 2002; 57(1):65-71. PubMed ID: 12090150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyotrophic lateral sclerosis and riluzole use during pregnancy: a case report.
    Scalco RS; Vieira MC; da Cunha Filho EV; Lago EG; da Silva IG; Becker J
    Amyotroph Lateral Scler; 2012 Sep; 13(5):471-2. PubMed ID: 22670879
    [No Abstract]   [Full Text] [Related]  

  • 6. [Riluzole-induced interstitial pneumonia in a case with amyotrophic lateral sclerosis].
    Takeshima S; Neshige S; Himeno T; Takamatsu K; Shimoe Y; Kuriyama M
    Rinsho Shinkeigaku; 2015; 55(11):840-3. PubMed ID: 26399668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole: a new agent for amyotrophic lateral sclerosis.
    Wagner ML; Landis BE
    Ann Pharmacother; 1997 Jun; 31(6):738-44. PubMed ID: 9184716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial pneumonia and other adverse events in riluzole-administered amyotrophic lateral sclerosis patients: a retrospective observational study.
    Inoue-Shibui A; Kato M; Suzuki N; Kobayashi J; Takai Y; Izumi R; Kawauchi Y; Kuroda H; Warita H; Aoki M
    BMC Neurol; 2019 Apr; 19(1):72. PubMed ID: 31029113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole use during pregnancy in a patient with amyotrophic lateral sclerosis: a case report.
    Kawamichi Y; Makino Y; Matsuda Y; Miyazaki K; Uchiyama S; Ohta H
    J Int Med Res; 2010; 38(2):720-6. PubMed ID: 20515588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
    Bellingham MC
    CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y; Takahashi Y
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rilutek (riluzole) Global Early Access Programme: an open-label safety evaluation in the treatment of amyotrophic lateral sclerosis.
    Debove C; Zeisser P; Salzman PM; Powe LK; Truffinet P
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Sep; 2(3):153-8. PubMed ID: 11771772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis.
    Morren JA; Galvez-Jimenez N
    Expert Opin Investig Drugs; 2012 Mar; 21(3):297-320. PubMed ID: 22303913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxicity by riluzole.
    González-Fernández C; Güell R; Anton A
    Med Clin (Barc); 2017 Dec; 149(12):561-562. PubMed ID: 28864086
    [No Abstract]   [Full Text] [Related]  

  • 16. ALS and myasthenia: An unusual association in a patient treated with riluzole.
    Restivo DA; Bianconi C; Ravenni R; De Grandis D
    Muscle Nerve; 2000 Feb; 23(2):294-5. PubMed ID: 10639627
    [No Abstract]   [Full Text] [Related]  

  • 17. An acute, life-threatening, hypersensitivity reaction to riluzole.
    Sorenson EJ
    Neurology; 2006 Dec; 67(12):2260-1. PubMed ID: 17190960
    [No Abstract]   [Full Text] [Related]  

  • 18. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
    Cheah BC; Vucic S; Krishnan AV; Kiernan MC
    Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing a patient's decision regarding riluzole: an early experience.
    Rudnicki SA
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S80-1. PubMed ID: 9419060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.